Trials / Conditions / Cardiovascular Disease and Lipoprotein(a)
Cardiovascular Disease and Lipoprotein(a)
3 registered clinical trials studyying Cardiovascular Disease and Lipoprotein(a) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and T NCT07517263 | Novartis Pharmaceuticals | Phase 3 |
| Active Not Recruiting | Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Pa NCT04023552 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) NCT03887520 | Novartis Pharmaceuticals | N/A |